Who Paid My Doc
FreeStyle Libre 2
Device Diabetes Care
PDI 00357599805005
General payments
$2,797,441
Research payments
$5,385,807
Through program year 2025, $2,797,441 in general payments and $5,385,807 in research payments were reported against FreeStyle Libre 2 (Diabetes Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $19,047 | 974 |
| 2025 | Research | $949,937 | 451 |
| 2024 | General | $49,573 | 2,236 |
| 2024 | Research | $1,273,025 | 332 |
| 2023 | General | $470,456 | 19,923 |
| 2023 | Research | $2,274,144 | 571 |
| 2022 | General | $1,710,187 | 59,364 |
| 2022 | Research | $624,575 | 115 |
| 2021 | General | $548,178 | 27,541 |
| 2021 | Research | $264,127 | 115 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
110,038 general · 1,584 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.